Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.

Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):303-9. doi: 10.1016/j.jtcvs.2011.10.059. Epub 2011 Dec 10.

2.

Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation.

Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, Ommen S.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):909-15; discussion 915-6. doi: 10.1016/j.jtcvs.2014.05.028. Epub 2014 May 16.

3.

Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy.

Ashikhmina EA, Schaff HV, Ommen SR, Dearani JA, Nishimura RA, Abel MD.

J Thorac Cardiovasc Surg. 2011 Jul;142(1):53-9. doi: 10.1016/j.jtcvs.2010.08.011. Epub 2010 Sep 29.

4.

Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.

Minakata K, Dearani JA, Schaff HV, O'Leary PW, Ommen SR, Danielson GK.

Ann Thorac Surg. 2005 Sep;80(3):851-6.

PMID:
16122442
5.

Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy.

Marwick TH, Nakatani S, Haluska B, Thomas JD, Lever HM.

Am J Cardiol. 1995 Apr 15;75(12):805-9.

PMID:
7717284
6.

Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation.

Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):317-24. doi: 10.1016/j.jtcvs.2009.10.045. Epub 2009 Dec 28.

7.

Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA.

J Am Coll Cardiol. 2005 Aug 2;46(3):470-6.

8.

Outcome of repair of myocardial bridging at the time of septal myectomy.

Kunkala MR, Schaff HV, Burkhart H, Sandhu GS, Spoon DB, Ommen SR, Sorajja P, Dearani JA.

Ann Thorac Surg. 2014 Jan;97(1):118-23. doi: 10.1016/j.athoracsur.2013.07.079. Epub 2013 Sep 24.

PMID:
24075496
9.

Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: the preferred approach for contemporary surgical candidates?

Gutermann H, Pettinari M, Van Kerrebroeck C, Vander Laenen M, Engelen K, Fret T, Dion RA.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1833-6. doi: 10.1016/j.jtcvs.2013.07.024. Epub 2013 Aug 26.

10.

Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction.

Helder MR, Schaff HV, Nishimura RA, Gersh BJ, Dearani JA, Ommen SR, Mereuta OM, Theis JD, Dogan A, Edwards WD.

Am J Cardiol. 2014 Nov 1;114(9):1396-9. doi: 10.1016/j.amjcard.2014.07.058. Epub 2014 Aug 12.

PMID:
25217455
11.

Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy.

McCully RB, Nishimura RA, Bailey KR, Schaff HV, Danielson GK, Tajik AJ.

J Am Coll Cardiol. 1996 May;27(6):1491-6.

12.

Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.

Hong J, Schaff HV, Ommen SR, Abel MD, Dearani JA, Nishimura RA.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1044-8. doi: 10.1016/j.jtcvs.2015.11.048. Epub 2015 Dec 8.

PMID:
26724969
13.

Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.

Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH.

Ann Thorac Surg. 2008 Jan;85(1):127-33.

PMID:
18154797
14.

Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.

Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, Agler D, Lytle BW, Lever HM, Desai MY.

Circ Cardiovasc Imaging. 2015 Jul;8(7):e003132. doi: 10.1161/CIRCIMAGING.115.003132.

15.

Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.

Kitamura M, Takayama M, Matsuda J, Kubota Y, Nakamura S, Takano H, Asai K, Shimizu W.

Am J Cardiol. 2015 Sep 15;116(6):945-51. doi: 10.1016/j.amjcard.2015.06.023. Epub 2015 Jun 26.

17.

Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy.

Kofflard MJ, van Herwerden LA, Waldstein DJ, Ruygrok P, Boersma E, Taams MA, Ten Cate FJ.

J Am Coll Cardiol. 1996 Jul;28(1):197-202.

18.

Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.

Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, Lever HM.

Circulation. 2013 Jul 16;128(3):209-16. doi: 10.1161/CIRCULATIONAHA.112.000849. Epub 2013 Jun 14.

19.

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ.

Circulation. 2006 Nov 21;114(21):2232-9. Epub 2006 Nov 6.

Items per page

Supplemental Content

Write to the Help Desk